InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by McKechnie Duncan. Officer active across 2 companies, notably Vertex Pharmaceuticals INC / MA. In total, 8 filings have been published. Split: 0 buy · 3 sells. Total volume traded: €2.8m. Activity tracked since 22 January 2026. The latest transaction was disclosed on 2 July 2026 (Cession). Regulator: SEC (Form 4). All data is free.
8 of 8 declarations
McKechnie Duncan is a declarant linked to VERTEX PHARMACEUTICALS INC / MA and to Vertex Pharmaceuticals INC / MA, where the listed role is EVP, Chief Commercial Officer. He has made 8 filings in total, and across the recent filings observed, the period runs from 2026-01-26 to 2026-07-07, with EUR 0 in buys and EUR 2827880 in sells, and the most frequent transaction nature being Cession.